George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPRP.L Regulatory News (PRP)

  • There is currently no data for PRP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Close Trading Update

10 Sep 2020 07:00

RNS Number : 5427Y
Prime People PLC
10 September 2020
 

 

10 September 2020

 

Prime People plc

("Prime People" or the "Group")

 

Pre-Close Trading Update

 

Prime People Plc (AIM: PRP), the global specialist recruitment business for professional and technical staff working in the Real Estate & Built Environment, Energy & Environmental and Technology, Digital & Data Analytics sectors, provides a pre-close unaudited trading update for the financial year ended 31 March 2020 and confirms that it intends to announce final results for the year ended 31 March 2020 at the end of October 2020.

 

The Company expects to report headline Revenue of approximately £23.85 million (2019: £24.66 million) and Net Fee Income ("NFI") of approximately £15.38 million (2019: £15.78 million) for the year ended 31 March 2020 which is expected to result in a profit before tax and of not less than £1.80 million* (2019: £2.47 million).

 

The Group's audit is ongoing, and the Directors are evaluating goodwill impairment and are considering an impairment charge for the year to 31 March 2020. The final valuation and subsequent impact on net profit will be disclosed in the full year audited financial statements. In these extraordinary times, the Group's results may be subject to audit adjustments that are unknown to the Directors at the time of this announcement.

 

Net cash, excluding the CBILS loan, at the date of this announcement is £2.23 million, up from the year-end position of £2.05 million (2019: £2.31 million) and the Group is well positioned to meet its working capital requirements.

 

Post year end, and as announced on 15 April 2020, as a direct result of COVID-19 we experienced a significant reduction in demand across our businesses with the impact varying by location and sector. Early action was taken by the Board to implement a range of measures to protect our business from the financial impact of COVID-19 including managing staff costs through furlough and other governmental schemes in the countries in which we operate, reductions in remuneration, minimising discretionary spend and rigorous cashflow management.

 

The depth and speed of impact on the global economy of COVID-19 has been unprecedented. The Group's trading has been severely impacted in the first six months of the new financial year. We have acted swiftly to take the necessary actions to manage our cost base to reflect expected levels of business. Whilst this process is constantly under review, we consider we have taken the right decisions to secure our businesses. We have the necessary cashflows and bank support (including the CBILS loan announced on 12 June 2020) for the foreseeable future and business appears to have settled at a sustainable level.

 

As previously announced, in order to strengthen the balance sheet and aid liquidity, the Board has taken the prudent decision not to pay a final dividend for the year ending 31 March 2020. The Board remains committed to paying progressive dividends as soon as appropriate and when there is better clarity on the financial consequences of COVID-19. Further, the Board intends to exercise its share buyback authority, as approved at the Group's most recent annual general meeting, and it is expected that the Group will make market purchases of ordinary shares of 10 pence each in the capital of the Group with a value of up to £0.25 million. A further announcement in respect of the share buyback programme will be made by the Group in due course as appropriate.

* this figure does not include the impact of any goodwill impairment charges.

Peter Moore, Chief Executive Officer, commented:

"The initial financial effects of the global pandemic were experienced as early as January by our Asian business. The effect on our other businesses started to have impact in early March. Our current financial year will be significantly affected by the pandemic as a consequence of material reductions in NFI and new job instructions. In the first six months of trading UK NFI is circa 40% lower than the comparable period last year and job instructions down by 54%. Our Asia business has suffered a circa 26% reduction in NFI and a 26% fall in job instructions.

 

"Since June there has been a modest increase in activity. However, half and full year profitability will be severely impacted. As a result of challenging trading, we expect to take a material reduction in the value of goodwill on our balance sheet.

 

"At this time the Group holds a strong cash position aided by CBILS arrangements.

 

"I would like to thank all our staff for their unfailing support, hard work and commitment during these difficult times."

 

 

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

 

For further information, please contact: 

 

Prime People

Robert Macdonald, Executive Chairman

020 7318 1785

Donka Zaneva-Todorinski, Finance Director

Cenkos Securities plc

020 7397 8900

Katy Birkin/Nick Wells/Harry Hargreaves

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTLLMPTMTJMBJM
Date   Source Headline
24th Jan 20227:00 amRNSSecondary Trading following Cancellation
18th Jan 20225:30 pmRNSPrime People
17th Jan 20222:03 pmRNSResult of Tender Offer
12th Jan 202212:39 pmRNSResult of General Meeting and Cancellation
11th Jan 20227:00 amRNSDirector/PDMR Shareholding
17th Dec 20217:00 amRNSProposed Cancellation and Tender Offer
19th Nov 20217:00 amRNSHalf-year Report
1st Sep 20213:26 pmRNSResult of AGM
4th Aug 20213:35 pmRNSPosting of Annual Report and Notice of AGM
23rd Jul 20217:00 amRNSFinal Results
28th May 20211:05 pmRNSExercise of Options and Transaction in Own Shares
24th May 20211:44 pmRNSExercise of Options and Transaction in Own Shares
1st Apr 20217:00 amRNSDirectorate Change
25th Feb 20219:20 amRNSBoard Change
29th Jan 20217:00 amRNSHalf-year Report
29th Dec 202010:30 amRNSGrant of Options
22nd Dec 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Dec 20202:38 pmRNSTransaction in Own Shares
23rd Nov 20201:49 pmRNSResult of General Meeting
10th Nov 20207:00 amRNSShare Buyback Programme and Interims Extension
4th Nov 202011:12 amRNSFinal Results
22nd Sep 20203:43 pmRNSResult of AGM
22nd Sep 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Sep 20207:00 amRNSIntention to purchase own shares
10th Sep 20207:00 amRNSPre-Close Trading Update
24th Aug 20207:00 amRNSNotice of AGM, Results & Accounts Extension
12th Jun 20201:12 pmRNSNew Banking Facility
15th Apr 20207:00 amRNSCOVID-19 Update
4th Feb 20203:00 pmRNSDirector/PDMR Shareholding
3rd Feb 20207:00 amRNSDirectorate Change
21st Jan 20201:00 pmRNSResult of Court Hearing
10th Jan 20204:41 pmRNSExercise of Options and Issue of Equity
8th Jan 20205:11 pmRNSExercise of Options and PDMR Shareholding
3rd Jan 202012:24 pmRNSResult of General Meeting
2nd Jan 20201:30 pmRNSPDMR Shareholding and Treasury Shares
23rd Dec 201912:20 pmRNSExercise of Options and PDMR Shareholding
19th Dec 20199:29 amRNSDirector/PDMR Shareholding
18th Dec 20197:00 amRNSProposed Return of Capital
5th Dec 201910:41 amRNSExercise of Options and Transaction in Own Shares
14th Nov 20197:00 amRNSHalf-year Report
27th Sep 201911:11 amRNSExercise of Options and Transaction in Own Shares
4th Sep 20194:10 pmRNSTransaction in Own Shares
2nd Sep 20193:04 pmRNSDirector/PDMR Shareholding
21st Aug 20191:52 pmRNSExercise of Options and Transaction in Own Shares
12th Aug 20192:20 pmRNSExercise of Options and PDMR Shareholding
24th Jul 201912:26 pmRNSResult of AGM
21st Jun 20197:00 amRNSFinal Results
29th Apr 20194:05 pmRNSDirector/PDMR Shareholding
5th Mar 20194:06 pmRNSTransaction in Own Shares and PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.